艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

未开盘 07-31 16:00:00 EDT

189.02

-0.29

-0.15%

盘后188.75

-0.27-0.14%

19:56 EDT

最高198.83	最低187.62	成交量1,035万
今开197.06	昨收189.31	日振幅5.92%
总市值3,339亿	流通市值3,332亿	总股本17.66亿
成交额19.89亿	换手率0.59%	流通股本17.63亿
市净率235.13	ROE88.40%	每股收益2.34
52周最高218.66	52周最低163.81	市盈率80.78
股息6.38	股息收益率0.03	ROA8.34%

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":189.02,"timestamp":1753992000000,"preClose":189.31,"halted":0,"volume":10347929,"hourTrading":{"tag":"盘后","latestPrice":188.7501,"preClose":189.02,"latestTime":"19:56 EDT","volume":795422,"amount":150755812.96315,"timestamp":1754006215614},"delay":0,"floatShares":1762792322,"shares":1766403027,"eps":2.339923,"marketStatus":"未开盘","change":-0.29,"latestTime":"07-31 16:00:00 EDT","open":197.06,"high":198.8256,"low":187.62,"amount":1989086983.7646198,"amplitude":0.059192,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.339923,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":189.31,"dividendRate":0.033753,"preHourTrading":{"tag":"盘前","latestPrice":197.57,"preClose":189.39,"latestTime":"09:29 EDT","volume":226796,"amount":45020421.20704,"timestamp":1753968599512},"postHourTrading":{"tag":"盘后","latestPrice":188.7501,"preClose":189.02,"latestTime":"19:56 EDT","volume":795422,"amount":150755812.96315,"timestamp":1754006215614},"volumeRatio":2.274205,"impliedVol":0.2638,"impliedVolPercentile":0.344},"requestUrl":"/m/hq/s/ABBV","defaultTab":"news","newsList":[{"id":"2555833321","title":"新药销量强劲，艾伯维二季度营收、EPS超预期，上调全年业绩指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2555833321","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555833321?lang=zh_cn&edition=full","pubTime":"2025-07-31 20:30","pubTimestamp":1753965035,"startTime":"0","endTime":"0","summary":"二季度毛利率 84.4%，营业利润率 44.3%。","market":"fut","thumbnail":"https://static.tigerbbs.com/806448d409f508326c0cdd58e43fdb5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/806448d409f508326c0cdd58e43fdb5f"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324433.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新药销量强劲，艾伯维(ABBV.US)上调2025年业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ABBV"],"gpt_icon":0},{"id":"1152863887","title":"异动解读 | 艾伯维上调年度盈利预期、业绩超预期，盘前大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152863887","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152863887?lang=zh_cn&edition=full","pubTime":"2025-07-31 20:28","pubTimestamp":1753964923,"startTime":"0","endTime":"0","summary":"美国制药巨头艾伯维今日盘前股价大涨5.12%，引发市场广泛关注。这一显著涨幅主要源于公司发布的积极财报和上调的年度盈利预期。根据公司最新公布的财报，艾伯维第二季度业绩超出华尔街预期。Skyrizi的季度销售额达44.2亿美元，超过预期的40亿美元；Rinvoq销售额为20.3亿美元，同样超过预期的19.7亿美元。受此鼓舞，艾伯维上调了2025年的盈利预期。公司现预计调整后的年度每股利润在11.88美元至12.08美元之间，高于此前11.67美元至11.87美元的预期。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ABBV"],"gpt_icon":0},{"id":"2555834892","title":"艾伯维盘前股价涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555834892","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555834892?lang=zh_cn&edition=full","pubTime":"2025-07-31 20:06","pubTimestamp":1753963572,"startTime":"0","endTime":"0","summary":"每经AI快讯，7月31日，艾伯维盘前股价涨超3%，因其上调财年每股收益指引。文章来源：每日经济新闻原标题：艾伯维盘前股价涨超3%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731201658a6cbab14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731201658a6cbab14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","LU2237443978.SGD","LU0158827948.USD","IE00BDGV0183.EUR","BK4588","LU0912757837.SGD","IE0004445239.USD","LU2089284900.SGD","IE00BSNM7G36.USD","BK4585","IE00B19Z3581.USD","LU1267930490.SGD","LU1291159041.SGD","IE0002270589.USD","LU1839511570.USD","IE00B2B36J28.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","LU1989771016.USD","BK4559","LU1037948897.HKD","LU0949170772.SGD","LU1551013425.SGD","LU2129689605.HKD","LU0310800379.SGD","LU0211328371.USD","LU1057294990.SGD","LU1244550221.USD","SG9999001440.SGD","LU2089283258.USD","LU0661504455.SGD","IE00BVYPNW00.USD","LU1585245621.USD","LU0545039389.USD","LU1989772923.USD","LU1934455277.USD","LU2129689431.USD","LU1023059063.AUD","LU0738911758.USD","ABBV","LU1267930573.SGD","LU1496350502.SGD","LU0128525929.USD","LU2237443382.USD","LU2468319806.SGD","LU2112291526.USD","SG9999015978.USD","LU0203347892.USD","BK4533","LU0882574055.USD"],"gpt_icon":0},{"id":"2555887039","title":"艾伯维上调全年调整后EPS预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2555887039","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555887039?lang=zh_cn&edition=full","pubTime":"2025-07-31 19:46","pubTimestamp":1753962364,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1291159041.SGD","IE00BSNM7G36.USD","IE0004445239.USD","LU0882574055.USD","BK4550","BK4533","LU0965509283.SGD","LU0965508806.USD","LU2237443382.USD","LU1430594728.SGD","LU0234570918.USD","IE0002141913.USD","SG9999015986.USD","LU0029864427.USD","LU0128525929.USD","IE0009355771.USD","LU1037948541.HKD","LU0708994859.HKD","IE00BVYPNV92.GBP","LU1074936037.SGD","LU1244550221.USD","LU2237443895.HKD","IE00BDGV0183.EUR","LU1989772923.USD","LU0943347566.SGD","IE0002270589.USD","LU0965509010.AUD","LU0738911758.USD","LU1585245621.USD","LU0170899867.USD","LU0545039389.USD","LU1023059063.AUD","BK4588","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","LU1496350171.SGD","IE00B3PB1722.GBP","LU0310799852.SGD","SG9999003800.SGD","LU0553294199.USD","LU1983299246.USD","LU0310800379.SGD","LU2133065610.SGD","IE00B19Z3581.USD","LU1551013342.USD","SG9999001440.SGD","BK4585","LU0211327993.USD","ABBV","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2555076335","title":"艾伯维公司7月30日成交额为9.50亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555076335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555076335?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:15","pubTimestamp":1753924519,"startTime":"0","endTime":"0","summary":"美东时间2025年7月30日，艾伯维公司成交额为9.50亿美元，成交额较昨日减少26.00%，当日成交量为500.84万股。艾伯维公司于2025年7月30日跌1.0%，报189.31美元，该股过去5个交易日跌0.65%，年初至今涨9.47%，过去60日跌3.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-30|9.50亿|-26.00%|500.84万|#|2025-07-29|12.84亿|80.00%|671.55万|#|2025-07-28|7.14亿|-0.88%|377.69万|#|2025-07-25|7.20亿|8.82%|378.68万|#|2025-07-24|6.62亿|-19.67%|346.31万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091525a46c6475&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731091525a46c6475&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","IE00BJJMRZ35.SGD","LU2237443622.USD","LU1291159041.SGD","IE00B42XCP33.USD","LU0545039389.USD","LU0234570918.USD","LU0943347566.SGD","SG9999015945.SGD","LU1732800096.USD","LU0820561909.HKD","IE0002270589.USD","LU1934455194.USD","LU0965509010.AUD","LU0122379950.USD","IE00BVYPNW00.USD","LU0158827948.USD","BK4585","LU1430594728.SGD","LU2237443978.SGD","IE00B3PB1722.GBP","ABBV","LU1551013342.USD","BK4566","LU2237443382.USD","LU0965509283.SGD","LU1718418525.SGD","LU0417517546.SGD","BK4559","LU0310799852.SGD","LU1267930490.SGD","LU2129689431.USD","LU0661504455.SGD","LU2468319806.SGD","LU1551013425.SGD","LU1093756168.USD","IE00BVYPNV92.GBP","LU0320765646.SGD","LU1732799900.SGD","LU0198837287.USD","IE00B19Z3581.USD","LU2237443895.HKD","LU1023059063.AUD","LU1496350171.SGD","LU1162221912.USD","LU0689472784.USD","LU0029864427.USD","LU1585245621.USD","IE0009355771.USD","LU1989772923.USD"],"gpt_icon":0},{"id":"2555075136","title":"精神健康成医药并购新风口！传艾伯维(ABBV.US)正洽谈收购Gilgamesh 估值或达10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555075136","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555075136?lang=zh_cn&edition=full","pubTime":"2025-07-31 08:52","pubTimestamp":1753923121,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1989772840.SGD","LU0689472784.USD","LU1093756168.USD","LU2468319806.SGD","LU2129689514.USD","LU0256863811.USD","LU1585245621.USD","BK4139","SG9999015978.USD","IE0002270589.USD","LU2237443549.SGD","IE00B3PB1722.GBP","LU1074936037.SGD","09939","BK4533","BK4581","LU2089984988.USD","LU1551013425.SGD","IE00BVYPNV92.GBP","LU0122379950.USD","LU0861579265.USD","LU0128525929.USD","LU0320765646.SGD","LU1093756325.SGD","LU0203345920.USD","LU0553294199.USD","LU2347655156.SGD","SG9999001440.SGD","SG9999015945.SGD","IE00B42XCP33.USD","IE00B4R5TH58.HKD","IE00BDGV0183.EUR","LU2112291526.USD","LU2089284900.SGD","LU0912757837.SGD","LU0256863902.USD","LU1732800096.USD","IE00B19Z3581.USD","LU1496350502.SGD","159938","LU1839511570.USD","LU0417517546.SGD","LU1244550494.USD","BK4559","LU0965509283.SGD","SG9999003800.SGD","ABBV","IE00BVYPNW00.USD","LU1023059063.AUD","LU1989771016.USD"],"gpt_icon":0},{"id":"2555042530","title":"AbbVie申请将Venclexta组合疗法推进到CLL一线治疗AbbVie files to move Venclexta combo into the CLL front line","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042530","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555042530?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:18","pubTimestamp":1753881480,"startTime":"0","endTime":"0","summary":"AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia , in combination with an AstraZeneca drug.AbbVie已为其基于Venclexta疗法的方案申请批准，用于既往未经治疗的慢性淋巴细胞白血病患者，该方案与阿斯利康的一种药物联合使用。Calquence, meanwhile, is already approved for first-line CLL, but with a label that calls for treatment until disease progression, and approval based on the AMPLIFY data would allow patients to take a holiday from treatment, potentially reducing long-term side effects.Calquence 已经被批准用于一线 CLL 治疗，但其标签上要求持续治疗直到疾病进展，而基于 AMPLIFY 数据的批准将允许患者暂停治疗，这可能会减少长期副作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021191294c3f0a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021191294c3f0a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B4R5TH58.HKD","LU0738911758.USD","LU1093756168.USD","LU2347655156.SGD","LU2089284900.SGD","IE00B19Z3581.USD","LU1732799900.SGD","LU2237443465.HKD","BK4566","IE0004445239.USD","LU0943347566.SGD","BK4550","LU2237443382.USD","LU1244550577.SGD","AZ","LU0661504455.SGD","LU1267930573.SGD","LU1839511570.USD","LU2129689431.USD","LU1718418525.SGD","IE0009355771.USD","LU1037948897.HKD","LU1934455277.USD","LU0912757837.SGD","IE00BGHQF631.EUR","LU1989772840.SGD","OS","LU0158827948.USD","BK4581","LU0417517546.SGD","IE00BDGV0183.EUR","LU2237443549.SGD","IE00BJJMRZ35.SGD","SG9999015986.USD","LU1983299246.USD","LU1037948541.HKD","LU1934455194.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU1732800096.USD","LU0456855351.SGD","LU1003077747.HKD","IE0002141913.USD","LU0234570918.USD","LU0256863902.USD","LU0985320562.USD","LU0820561818.USD","BK4533","LU1057294990.SGD","ABBV"],"gpt_icon":0},{"id":"2555054519","title":"强生(JNJ.US)/艾伯维(ABBV.US)遇劲敌！礼来(LLY.US)BTK抑制剂三期临床达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2555054519","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555054519?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:32","pubTimestamp":1753795966,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来周二宣布，其经美国食品药品监督管理局批准的布鲁顿酪氨酸激酶抑制剂Jaypirca在针对慢性淋巴细胞白血病或小淋巴细胞淋巴瘤患者的三期头对头临床试验中，达到了主要研究终点，成功挑战了强生与艾伯维的同类重磅药物Imbruvica。这项名为BRUIN CLL-314的三期研究直接比较了Jaypirca与Imbruvica在初诊或未接受过BTK抑制剂治疗的CLL/SLL患者中的疗效。目前，Jaypirca与Imbruvica均是美国FDA批准的口服靶向药物，获批适应症包括CLL和SLL等血液系统恶性肿瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1127390331.HKD","LU1430594728.SGD","LU0256863902.USD","LU1934455277.USD","LU2237438978.USD","LU0211328371.USD","BK4568","LU2471134796.USD","LU1868837300.USD","LU0266013472.USD","LU0861579265.USD","SG9999018865.SGD","IE00B1BXHZ80.USD","SG9999014898.SGD","LU1291159041.SGD","LU0795875086.SGD","LU0170899867.USD","BK4585","LU2237443895.HKD","JNJ","IE00BJT1NW94.SGD","LU2236285917.USD","LU0320765992.SGD","LU2347655156.SGD","SG9999015978.USD","LU1935042991.SGD","LU1989772923.USD","LU2129689431.USD","LU0823416689.USD","LLY","LU2324357040.USD","LU1244550494.USD","ABBV","LU0640476718.USD","IE00BVYPNV92.GBP","LU0109394709.USD","LU2112291526.USD","LU0820561818.USD","LU0320765059.SGD","LU1003077747.HKD","LU2430703178.SGD","LU0323591593.USD","SG9999015986.USD","SGXZ51526630.SGD","LU0345769128.USD","LU2361044949.HKD","LU1093756325.SGD","LU2360106947.USD","LU0882574139.USD","LU2462157665.USD"],"gpt_icon":1},{"id":"2555084212","title":"艾伯维公司7月28日成交额为7.14亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555084212","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555084212?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:15","pubTimestamp":1753751719,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，艾伯维公司成交额为7.14亿美元，成交额较昨日减少0.88%，当日成交量为377.69万股。艾伯维公司于2025年7月28日跌0.92%，报188.52美元，该股过去5个交易日涨1.99%，年初至今涨9.02%，过去60日跌2.53%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-28|7.14亿|-0.88%|377.69万|#|2025-07-25|7.20亿|8.82%|378.68万|#|2025-07-24|6.62亿|-19.67%|346.31万|#|2025-07-23|8.24亿|-0.57%|434.45万|#|2025-07-22|8.28亿|-10.20%|443.21万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091529a46889b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091529a46889b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3PB1722.GBP","BK4534","LU1162221912.USD","LU1585245621.USD","SG9999001440.SGD","IE0002270589.USD","LU2129689431.USD","LU2129689605.HKD","LU1934455277.USD","IE00BJT1NW94.SGD","LU0738911758.USD","LU0965509010.AUD","LU1551013425.SGD","LU0545039389.USD","LU0320765646.SGD","SG9999011175.SGD","LU2347655156.SGD","LU0795875169.SGD","LU2133065610.SGD","ABBV","LU1989772923.USD","LU0114720955.EUR","BK4139","LU1732800096.USD","LU0234572021.USD","LU0708994859.HKD","LU0661504455.SGD","LU0553294199.USD","LU0820561818.USD","LU1718418525.SGD","IE00BSNM7G36.USD","IE00BVYPNW00.USD","LU1732799900.SGD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU2089284900.SGD","BK4533","LU1061106388.HKD","LU0965508806.USD","LU2237443465.HKD","LU2023251221.USD","IE0009355771.USD","LU0861579265.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","LU0456855351.SGD","LU1093756325.SGD","LU2089283258.USD","IE00B2B36J28.USD","LU2087621335.USD"],"gpt_icon":0},{"id":"2554734136","title":"艾伯维公司7月24日成交额为6.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554734136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554734136?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:15","pubTimestamp":1753406119,"startTime":"0","endTime":"0","summary":"美东时间2025年7月24日，艾伯维公司成交额为6.62亿美元，成交额较昨日减少19.67%，当日成交量为346.31万股。艾伯维公司于2025年7月24日涨0.15%，报190.83美元，该股过去5个交易日跌0.3%，年初至今涨10.35%，过去60日涨0.08%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-24|6.62亿|-19.67%|346.31万|#|2025-07-23|8.24亿|-0.57%|434.45万|#|2025-07-22|8.28亿|-10.20%|443.21万|#|2025-07-21|9.22亿|-8.80%|495.48万|#|2025-07-18|10.11亿|9.10%|533.22万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725091525a46227a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250725091525a46227a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0738911758.USD","LU1162221912.USD","LU0965509283.SGD","IE00B2B36J28.USD","ABBV","LU1718418525.SGD","LU1057294990.SGD","LU0882574055.USD","BK4566","LU1989772840.SGD","LU1989772923.USD","IE00BJJMRZ35.SGD","IE00B42XCP33.USD","IE0004445239.USD","LU0122379950.USD","LU0795875169.SGD","LU1430594728.SGD","IE00BSNM7G36.USD","LU2129689431.USD","LU0114720955.EUR","LU1732800096.USD","IE00B4R5TH58.HKD","BK4588","LU1037948897.HKD","LU1061106388.HKD","LU2237443622.USD","LU0861579265.USD","LU2237443978.SGD","LU0234572021.USD","IE0002141913.USD","SG9999015986.USD","BK4585","LU0203347892.USD","LU1551013425.SGD","LU2237443549.SGD","LU2089283258.USD","LU0417517546.SGD","LU1585245621.USD","SG9999015978.USD","LU2089984988.USD","LU1093756168.USD","LU2023251221.USD","IE00B19Z3581.USD","IE0002270589.USD","BK4139","LU0256863902.USD","LU0949170772.SGD","LU0310799852.SGD","LU0211327993.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2553214302","title":"艾伯维公司7月23日成交额为8.24亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553214302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553214302?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:15","pubTimestamp":1753319718,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，艾伯维公司成交额为8.24亿美元，成交额较昨日减少0.57%，当日成交量为434.45万股。艾伯维公司于2025年7月23日涨1.84%，报190.55美元，该股过去5个交易日跌0.02%，年初至今涨10.19%，过去60日涨3.3%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-23|8.24亿|-0.57%|434.45万|#|2025-07-22|8.28亿|-10.20%|443.21万|#|2025-07-21|9.22亿|-8.80%|495.48万|#|2025-07-18|10.11亿|9.10%|533.22万|#|2025-07-17|9.27亿|-21.45%|485.31万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091531a6be7b98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091531a6be7b98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0256863811.USD","LU0170899867.USD","IE00B2B36J28.USD","LU0234570918.USD","LU1003077747.HKD","IE00B4R5TH58.HKD","LU0256863902.USD","LU2089984988.USD","ABBV","LU0234572021.USD","LU1037948541.HKD","LU0795875086.SGD","LU1732800096.USD","LU1496350171.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","BK4566","LU1244550577.SGD","LU0114720955.EUR","LU1934455863.HKD","IE0002270589.USD","BK4534","LU0912757837.SGD","LU2089284900.SGD","LU1162221912.USD","SG9999003800.SGD","SG9999011175.SGD","LU1244550221.USD","LU0158827948.USD","LU2089283258.USD","LU1057294990.SGD","LU2133065610.SGD","LU0310799852.SGD","LU0661504455.SGD","IE00BGHQF631.EUR","BK4139","LU0320765646.SGD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU0943347566.SGD","LU0965508806.USD","LU0965509101.SGD","LU0211327993.USD","LU1989772923.USD","LU0985320562.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU2237443549.SGD","LU1839511570.USD"],"gpt_icon":0},{"id":"2553288521","title":"艾伯维公司7月21日成交额为9.22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553288521?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:15","pubTimestamp":1753146918,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，艾伯维公司成交额为9.22亿美元，成交额较昨日减少8.80%，当日成交量为495.48万股。艾伯维公司于2025年7月21日跌2.33%，报184.85美元，该股过去5个交易日跌2.65%，年初至今涨6.89%，过去60日涨5.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-21|9.22亿|-8.80%|495.48万|#|2025-07-18|10.11亿|9.10%|533.22万|#|2025-07-17|9.27亿|-21.45%|485.31万|#|2025-07-16|11.80亿|-5.99%|620.27万|#|2025-07-15|12.55亿|61.16%|672.92万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722091532a6b9602f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722091532a6b9602f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1267930490.SGD","BK4550","LU2089284900.SGD","LU2347655156.SGD","LU0029864427.USD","SG9999015945.SGD","LU2237443978.SGD","LU0203347892.USD","LU0211327993.USD","IE00B42XCP33.USD","LU1244550494.USD","LU0417517546.SGD","ABBV","LU1291159041.SGD","LU2237443382.USD","LU1074936037.SGD","LU0158827948.USD","LU0985320562.USD","SG9999015952.SGD","BK4581","LU0820561909.HKD","LU1244550577.SGD","LU2133065610.SGD","LU1496350502.SGD","IE00BVYPNW00.USD","LU1551013342.USD","LU0708994859.HKD","LU1061106388.HKD","LU0882574055.USD","LU2089283258.USD","SG9999015978.USD","LU1093756168.USD","LU2023251221.USD","IE0004445239.USD","LU0256863902.USD","LU0310799852.SGD","IE0002141913.USD","LU1585245621.USD","LU0553294199.USD","IE00BGHQF631.EUR","LU0795875169.SGD","LU0820561818.USD","LU1037948897.HKD","LU1037948541.HKD","SG9999001440.SGD","BK4533","LU1989771016.USD","LU1267930573.SGD","LU2237443622.USD","LU0545039389.USD"],"gpt_icon":0},{"id":"2552641575","title":"艾伯维公司7月18日成交额为10.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552641575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552641575?lang=zh_cn&edition=full","pubTime":"2025-07-19 09:15","pubTimestamp":1752887718,"startTime":"0","endTime":"0","summary":"美东时间2025年7月18日，艾伯维公司成交额为10.11亿美元，成交额较昨日增加9.10%，当日成交量为533.22万股。艾伯维公司于2025年7月18日跌1.12%，报189.26美元，该股过去5个交易日跌0.8%，年初至今涨9.44%，过去60日涨9.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-18|10.11亿|9.10%|533.22万|#|2025-07-17|9.27亿|-21.45%|485.31万|#|2025-07-16|11.80亿|-5.99%|620.27万|#|2025-07-15|12.55亿|61.16%|672.92万|#|2025-07-14|7.79亿|-18.85%|407.28万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719091530a4547eb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719091530a4547eb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0943347566.SGD","LU0912757837.SGD","IE0004445239.USD","LU1244550577.SGD","LU1732799900.SGD","LU2112291526.USD","SG9999015978.USD","LU0985320562.USD","LU1430594728.SGD","IE00BDGV0183.EUR","LU0545039389.USD","IE00BGHQF631.EUR","LU2237443549.SGD","LU0553294199.USD","LU1003077747.HKD","LU1934455277.USD","LU0861579265.USD","LU1718418525.SGD","LU2237443895.HKD","LU2237443622.USD","IE0002270589.USD","LU2237443978.SGD","SG9999001440.SGD","IE0009355771.USD","SG9999015952.SGD","LU2347655156.SGD","LU0234570918.USD","LU1496350171.SGD","LU2087621335.USD","LU0965509010.AUD","LU1093756168.USD","BK4581","IE0002141913.USD","LU0882574055.USD","LU2133065610.SGD","LU0320765646.SGD","LU1983299246.USD","LU1244550494.USD","LU2089984988.USD","LU0310799852.SGD","LU1496350502.SGD","ABBV","LU0738911758.USD","LU1989772840.SGD","LU1093756325.SGD","LU0158827948.USD","LU1061106388.HKD","LU0965508806.USD","LU0211327993.USD","LU2089283258.USD"],"gpt_icon":0},{"id":"2552171392","title":"艾伯维公司7月16日成交额为11.80亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552171392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552171392?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:15","pubTimestamp":1752714918,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，艾伯维公司成交额为11.80亿美元，成交额较昨日减少5.99%，当日成交量为620.27万股。艾伯维公司于2025年7月16日涨2.25%，报190.58美元，该股过去5个交易日涨0.85%，年初至今涨10.21%，过去60日涨11.12%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-16|11.80亿|-5.99%|620.27万|#|2025-07-15|12.55亿|61.16%|672.92万|#|2025-07-14|7.79亿|-18.85%|407.28万|#|2025-07-11|9.60亿|-18.60%|499.10万|#|2025-07-10|11.79亿|10.83%|604.96万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091532a44fbdbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091532a44fbdbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BDGV0183.EUR","LU0820561818.USD","LU1093756168.USD","LU2089284900.SGD","IE00B42XCP33.USD","LU1037948541.HKD","SG9999003800.SGD","LU0943347566.SGD","SG9999015952.SGD","BK4585","LU2237443895.HKD","LU0861579265.USD","BK4566","LU0949170772.SGD","BK4139","IE00B3PB1722.GBP","IE00B19Z3581.USD","LU0170899867.USD","LU1267930490.SGD","LU0256863902.USD","LU1839511570.USD","LU2023251221.USD","BK4588","IE00BSNM7G36.USD","LU2347655156.SGD","LU1023059063.AUD","ABBV","LU0158827948.USD","IE0004445239.USD","LU1496350502.SGD","LU1093756325.SGD","IE00B19Z3B42.SGD","LU1989772840.SGD","LU1732799900.SGD","LU1934455863.HKD","SG9999015945.SGD","LU2237443549.SGD","IE0002141913.USD","LU1929549753.HKD","LU1037948897.HKD","LU0211327993.USD","LU2129689431.USD","LU0965509283.SGD","LU0310800379.SGD","IE00BGHQF631.EUR","LU0820561909.HKD","BK4581","LU0456855351.SGD","LU0417517546.SGD","LU0203345920.USD"],"gpt_icon":0},{"id":"2552177419","title":"医药生物行业周报：艾伯维引进CD3／BCMA／CD38三抗 关注国内三抗布局创新药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2552177419","media":"甬兴证券有限公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552177419?lang=zh_cn&edition=full","pubTime":"2025-07-17 00:00","pubTimestamp":1752681600,"startTime":"0","endTime":"0","summary":"恒生医疗保健指数上涨0.05%，板块整体跑输恒生指数0.88pct。在恒生12 个一级子行业中，医疗保健行业周涨跌幅排名为第9 位。核心观点重磅交易落地，艾伯维引进CD3/BCMA/CD38 管线。投 资建议此次艾伯维引进CD3/BCMA/CD38三抗，进一步点燃了三抗赛道的热情，建议关注国内有三抗布局的企业，如泽璟制药-U、信达生物、神州细胞、基石药业-B、先声药业、汇宇制药-W、恒瑞医药等。风险提示销售不及预期风险，医药政策影响不确定的风险，新药研发失败风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071709103597a911ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071709103597a911ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999001440.SGD","LU1934455277.USD","IE00BKVL7J92.USD","ABBV","LU1988902786.USD","LU2237443895.HKD","SG9999004303.SGD","BK4566","LU1064131342.USD","LU0689472784.USD","LU1496350502.SGD","IE00BGHQF631.EUR","LU1720051108.HKD","IE0004445239.USD","LU0122379950.USD","SGXZ23171101.USD","LU2129689431.USD","LU0320765646.SGD","LU0310800379.SGD","LU0648001328.SGD","IE00B4R5TH58.HKD","LU1732800096.USD","BK4588","DE","IE00BJT1NW94.SGD","LU0345781412.USD","LU2264538146.SGD","BK4152","LU0965508806.USD","ORR","LU2129689514.USD","SG9999011175.SGD","LU1861219969.SGD","SG9999015986.USD","BK4585","LU0985320562.USD","LU1003077747.HKD","LU1861214812.USD","LU0417517546.SGD","LU0234570918.USD","LU1093756168.USD","LU0965509010.AUD","LU2023251221.USD","IE0002270589.USD","LU1917777945.USD","LU1291159041.SGD","LU0942090050.USD","LU0211327993.USD","LU2112291526.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2551167982","title":"艾伯维公司7月14日成交额为7.79亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551167982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551167982?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:15","pubTimestamp":1752542119,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，艾伯维公司成交额为7.79亿美元，成交额较昨日减少18.85%，当日成交量为407.28万股。艾伯维公司于2025年7月14日跌0.48%，报191.52美元，该股过去5个交易日涨2.07%，年初至今涨9.8%，过去60日涨8.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-14|7.79亿|-18.85%|407.28万|#|2025-07-11|9.60亿|-18.60%|499.10万|#|2025-07-10|11.79亿|10.83%|604.96万|#|2025-07-09|10.64亿|-21.26%|559.45万|#|2025-07-08|13.51亿|-35.10%|710.69万|艾伯维是一家制药公司，主要从事免疫学和肿瘤学领域的业务。该公司于 2013 年初从雅培分拆出来。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715091528a6a9cca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715091528a6a9cca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237443978.SGD","LU2237443622.USD","LU0661504455.SGD","ABBV","BK4588","IE00BJT1NW94.SGD","LU1934455194.USD","LU2237443895.HKD","LU1061106388.HKD","LU2129689605.HKD","IE00BDGV0183.EUR","LU0256863902.USD","LU0114720955.EUR","LU1162221912.USD","LU1267930573.SGD","IE00BJJMRZ35.SGD","IE00BVYPNV92.GBP","SG9999015952.SGD","LU1057294990.SGD","LU2237443549.SGD","LU0545039389.USD","LU1093756168.USD","LU0965509283.SGD","LU0912757837.SGD","LU0820561909.HKD","LU0965509101.SGD","LU1037948897.HKD","LU0310799852.SGD","LU0965508806.USD","LU0985320562.USD","LU2237443382.USD","SG9999001440.SGD","LU1989772840.SGD","LU0170899867.USD","LU2089984988.USD","BK4550","LU1989772923.USD","IE00B4R5TH58.HKD","LU1037948541.HKD","LU1934455277.USD","LU1267930490.SGD","LU2347655156.SGD","LU0198837287.USD","LU1093756325.SGD","BK4559","IE0002141913.USD","LU2468319806.SGD","LU2089283258.USD","LU0256863811.USD","LU1732800096.USD"],"gpt_icon":0},{"id":"2551974502","title":"三抗市场再起波澜！艾伯维19.25亿美元引进一款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2551974502","media":"制药网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551974502?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:10","pubTimestamp":1752473456,"startTime":"0","endTime":"0","summary":"IGI则将获得7亿美元的预付款，同时还有资格获得高达12.25亿美元的开发、监管和商业化里程碑付款，外加基于净销售额的两位数分层特许权使用费，总交易金额最高可达19.25亿美元，足以彰显双方对这款药物的高度信心。根据协议，艾伯维将支付给先声再明一定的预付款，以及最高10.55亿美元的选择性权益付款和里程碑付款，外加大中华区以外地区的销售分成。短短半年内，艾伯维在三抗领域连续出手，足以看出其对这一领域的重视和布局的决心。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507141413469541b2c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507141413469541b2c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2133065610.SGD","TRAE","LU2237443549.SGD","BK4588","LU2237443978.SGD","LU2112291526.USD","BK4550","LU1989771016.USD","LU2347655156.SGD","LU0708994859.HKD","LU0256863811.USD","LU2065731478.USD","LU1989772840.SGD","LU1244550494.USD","SG9999015986.USD","LU1496350502.SGD","LU0417517546.SGD","PD","IE00B19Z4B17.USD","LU1267930490.SGD","LU1093756325.SGD","SG9999001440.SGD","LU0203347892.USD","LU1244550221.USD","LU1934455194.USD","IE00BVYPNW00.USD","IE00B7SZL793.SGD","LU1057294990.SGD","LU0882574055.USD","LU0158827948.USD","LU0795875169.SGD","ORR","LU0234570918.USD","LU0965509283.SGD","LU0320765646.SGD","PK","LU1244550577.SGD","BK4534","CRS","LU0820561818.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","ABBV","LU2129689514.USD","LU2237443895.HKD","LU1496350171.SGD","LU2468319806.SGD","LU0738911758.USD","LU1162221912.USD","LU1291159041.SGD"],"gpt_icon":0},{"id":"2551924123","title":"TCE + In vivo CAR-T：艾伯维在下一盘大棋","url":"https://stock-news.laohu8.com/highlight/detail?id=2551924123","media":"生物制药小编","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551924123?lang=zh_cn&edition=full","pubTime":"2025-07-14 09:21","pubTimestamp":1752456066,"startTime":"0","endTime":"0","summary":"近一年多来，艾伯维频频出手，通过引进或并购的方式扩充自己的TCE及In vivo CAR-T管线及平台。特别是从最近一年的引进及并购交易来看，艾伯维在血液瘤的布局侧重于TCE及In vivo CAR-T。图7.AbCellera的CD28平台示意图2、In vivo CAR-T自2017年首次获批以来，自体CAR-T细胞疗法彻底改变了血液瘤的治疗，给对以往疗法失败的患者带来了希望。与此同时，近年来自体CAR-T细胞疗法在自免领域也取得了一系列的突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714092338a6a7787a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714092338a6a7787a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BDGV0183.EUR","LU1093756168.USD","LU1074936037.SGD","LU1244550494.USD","IE00B42XCP33.USD","LU2087621335.USD","LU2112291526.USD","SG9999015986.USD","IE0002270589.USD","LU0985320562.USD","LU2089984988.USD","LU2237443895.HKD","LU0310799852.SGD","LU0861579265.USD","BK4566","IE00BVYPNW00.USD","IE00B3PB1722.GBP","LU1267930490.SGD","BK4534","LU0256863902.USD","LU1496350171.SGD","LU2237443978.SGD","CAR","LU1057294990.SGD","LU0795875169.SGD","LU1023059063.AUD","LU1934455277.USD","LU2347655156.SGD","LU1732800096.USD","ABBV","LU2129689514.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU1162221912.USD","SG9999015978.USD","BK4022","SG9999015945.SGD","LU2237443549.SGD","LU1244550577.SGD","IE0009355771.USD","LU1929549753.HKD","LU1037948897.HKD","LU1003077747.HKD","LU2129689605.HKD","LU0965509283.SGD","IE00BGHQF631.EUR","LU1718418525.SGD","LU1551013342.USD","LU0456855351.SGD"],"gpt_icon":0},{"id":"1162545404","title":"700亿美元并购风暴，制药巨头狂砸CNS赛道的背后","url":"https://stock-news.laohu8.com/highlight/detail?id=1162545404","media":"环球老虎财经app","labels":["analysis"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162545404?lang=zh_cn&edition=full","pubTime":"2025-07-13 12:30","pubTimestamp":1752381002,"startTime":"0","endTime":"0","summary":"而这场700亿美元并购风暴的背后，却隐藏着三重关键动因。2024年，Ocrevus销售额突破76亿美元，成为CNS领域最畅销药物；同期Kesimpta销售额亦突破32亿美元，且还在以49%的增速持续攀升。整体来看，强生堪称CNS领域的“六边形战士”。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/dklmY90BbLDKTwa-2-hj6Q","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1605014229936","symbols":["ABBV","JNJ","PFE"],"gpt_icon":1},{"id":"2551912315","title":"19.25亿，艾伯维引进CD3/BCMA/CD38管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2551912315","media":"药渡","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551912315?lang=zh_cn&edition=full","pubTime":"2025-07-13 07:30","pubTimestamp":1752363052,"startTime":"0","endTime":"0","summary":"ISB 2001 是同类首创的三特异性 T 细胞接合剂，靶向骨髓瘤细胞上的 BCMA 和 CD38 以及 T 细胞上的 CD3，目前正处于复发/难治性多发性骨髓瘤的 I 期临床研究。在25 名对抗 CD38 疗法有耐药性的患者中，ORR 为 72%，CR/sCR 率为 24%。在15 名接受过 BCMA 靶向治疗的患者中，ORR 为 73%，CR/sCR 率为 27%。CD3/BCMA/CD38三抗业界做的人不多，其实2020年有文章初步显示，做三抗具有一定可行性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713073357a447180c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250713073357a447180c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B66KJ199.SGD","LU0965508806.USD","LU1267930490.SGD","LU0965509283.SGD","LU2089284900.SGD","IE00BVYPNW00.USD","IE00BDGV0183.EUR","LU1267930573.SGD","LU1914381329.SGD","BK4566","IE0004445239.USD","BK4568","LU0456855351.SGD","IE00BJJMRZ35.SGD","SG9999015945.SGD","IE00B7SZL793.SGD","LU0708994859.HKD","LU1093756325.SGD","LU0861579265.USD","LU0792757196.USD","LU1894683264.USD","LU1066051225.USD","LU0320765646.SGD","LU2087621335.USD","LU0256863811.USD","LU1032466523.USD","LU2430703251.USD","IE00B4R5TH58.HKD","LU0889566641.SGD","CRS","JNJ","ABBV","LU2602419157.SGD","LU0689472784.USD","IGI","LU0211327993.USD","LU0820561909.HKD","LU1244550221.USD","LU1674673691.USD","LU2347655156.SGD","BK4592","LU2505996681.GBP","BK4007","LU2237443465.HKD","LU0114720955.EUR","LU1496350502.SGD","RR","IE00B3PB1722.GBP","LU1934455277.USD","IE00B2B36J28.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.0051},{"period":"3month","weight":-0.0476},{"period":"6month","weight":0.0278},{"period":"1year","weight":0.02},{"period":"ytd","weight":0.0637}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.1153},{"period":"6month","weight":0.0503},{"period":"1year","weight":0.1475},{"period":"ytd","weight":0.0785}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.018856},{"month":2,"riseRate":0.846154,"avgChangeRate":0.038959},{"month":3,"riseRate":0.769231,"avgChangeRate":0.006022},{"month":4,"riseRate":0.615385,"avgChangeRate":0.009221},{"month":5,"riseRate":0.615385,"avgChangeRate":0.002163},{"month":6,"riseRate":0.461538,"avgChangeRate":0.008788},{"month":7,"riseRate":0.538462,"avgChangeRate":0.01232},{"month":8,"riseRate":0.5,"avgChangeRate":-0.0014},{"month":9,"riseRate":0.5,"avgChangeRate":0.007813},{"month":10,"riseRate":0.666667,"avgChangeRate":0.012917},{"month":11,"riseRate":0.75,"avgChangeRate":0.065469},{"month":12,"riseRate":0.666667,"avgChangeRate":0.027572}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}